A CRISPR-Cas9 screen recently showed that MYCN-amplified NB cells were also highly dependent on EZH2 activity,35 a finding also supported by our observations whereby the combined EHMT+EZH2 activity score strongly correlated with EHMTs, EZH2 and MYCN expression. The gene discussed is MYCN; the disease is neuroblastoma.